InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.14
(
-0.10%
)
US TECH 100
19,280.80
(
0.09%
)
Dow Jones
39,070.78
(
-0.24%
)
Brent Oil
84.99
(
-0.50%
)
Bitcoin
60,635.99
(
-1.58%
)

Replies to post #96301 on Biotech Values

Replies to #96301 on Biotech Values

DewDiligence

05/25/10 4:30 AM

#96303 RE: genisi #96301

Good luck to Teva on that program. The arena for anti-CD20 biosimilars / Rituxan knockoffs has become very crowded.